Drug company and CEO pay $47 million over alleged kickbacks and false claims
By 
Adrianne Appel2024-11-15T19:28:00
A pharmaceutical company and its chief executive have agreed to pay $47 million to settle allegations, first brought by whistleblowers, that the company paid kickbacks and filed false claims, the Department of Justice said.
The U.S. Department of Health and Human Services (HHS), which manages Medicare, Medicaid and other federal health programs, takes a hard line against free tests, drugs or offerings provided to patients or doctors, actions which may induce them to prescribe or use a particular drug or service, or use of medical equipment.
The HHS foots part of the bills for these patients, and it believes that free offerings are kickbacks intended to steer patients to services and drugs they otherwise may not use. If the HHS concludes that kickbacks were at play, it considers any related bills or “claims” to be false claims and a violation.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
News BriefDOD health contractors rack up more than $100M in excess payments, DOJ alleges
Six health centers that contracted with the Department of Defense, intentionally overbilled the government for more than $100 million, the Department of Justice alleged in announcing a settlement with one of the plans.
-
News BriefSenate votes along party lines to confirm RFK Jr. as secretary of HHS
The U.S. Senate has approved Robert F. Kennedy, Jr. to lead the Department of Health and Human Services, placing President Donald Trump’s controversial pick at the helm of a $1.7 trillion department in transition.
-
News BriefArizona couple pleads guilty in vast $1.2B skin graft false claims case
Two owner-operators of three Arizona medical companies have pleaded guilty to billing more than $1.2 billion in false and fraudulent claims to Medicare and other government health programs in less than two years, the Department of Justice said.
More from Regulatory Enforcement
-
News BriefFTC shuts down student loan firms over deceptive debt relief practices
The U.S. Federal Trade Commission (FTC) took action against a pair of student loan debt relief companies for allegedly deceiving borrowers. The move came despite the Trump administration’s broader efforts to roll back enforcement actions against businesses since taking office.
-
News BriefCoinbase faces a leftover SEC probe as crypto enforcement loses steam
After dismissing its lawsuit against the crypto exchange Coinbase in March, a second investigation into the exchange by the Securities and Exchange Commission has surfaced, according to a report from the New York Times. This comes as a bit of a surprise after the Trump administration has been scaling down ...
-
News BriefStates like New York, Pennsylvania stepping up to fill regulatory void left by federal agencies
As the Consumer Financial Protection Bureau steps back from its core mission of protecting American consumers, states like New York and Pennsylvania are stepping up to fill the regulatory void.